Penn Medicine Provider
Dermatology
Christoph Thomas Ellebrecht, MD
5.0
(249)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737

About me

  • Assistant Professor of Dermatology

Education and training

  • Medical School: University of Lübeck
  • Residency: University Hospital Schleswig-Holstein
  • Residency: Temple University Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

249 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
very attentive
May 2025
5.0
5.0
he's the best!
May 2025
5.0
5.0
dr. e is just so knowledgeable and tailors your treatment plan to you.
April 2025
5.0
5.0
dr ellebrecht listened to my questions, did a thorough exam and explained it all to me.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Ellebrecht is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Corbett T. Berry, Caitlin S. Frazee, Patrick J. Herman, Sisi Chen, Anna Chen, Yvonne Kuo, Christoph T. Ellebrecht Current advancements in cellular immunotherapy for autoimmune disease , Semin Immunopathol 47, 7 (2025), 47(7): 2025

Christoph Ellebrecht, Aimee Payne Pemphigus , Fitzpatrick's Dermatology 10th edition: 2025

Lee CS, Chen S, Berry CT, Kelly AR, Herman PJ, Oh S, O'Connor RS, Payne AS, Ellebrecht CT Fate induction in CD8 CAR T cells through asymmetric cell division , Nature: 2024

Corbett Berry, Casey Lee, Sisi Chen, Caitlin Frazee, Patrick Herman, Anna Chen, Andre Kelly, Roderick O'Connor, Christoph Ellebrecht Asymmetric epigenetic and metabolic remodeling of engineered CD4 T cells drives divergent cell fate , Society of Investigative Dermatology: 2024

Chat, Vipawee S., Ellebrecht, Christoph T., Kingston, Paige, Gondo, George, Bell, Stacie, Cordoro, Kelly M., Desai, Seemal R., Duffin, Kristina C., Feldman, Steven R., Garg, Amit, Gelfand, Joel M., Gladman, Dafna, Green, Lawrence J., Gudjonsson, Johann, Han, George, Hawkes, Jason E., Kircik, Leon, Koo, John, Langley, Richard, Lebwohl, Mark, Michael Lewitt, G., Liao, Wilson, Martin, George, Orbai, Ana-Maria, Reddy, Soumya M., Richardson, Veronica, Ritchlin, Christopher T., Schwartzman, Sergio, Siegel, Evan L., Van Voorhees, Abby S., Wallace, Elizabeth B., Weinberg, Jeffrey M., Winthrop, Kevin L., Yamauchi, Paul, Armstrong, April W. Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation , Journal of the American Academy of Dermatology: 2024

Oh S, Mao X, Manfredo-Vieira S, Lee J, Patel D, Choi EJ, Alvarado A, Cottman-Thomas E, Maseda D, Tsao PY, Ellebrecht CT, Khella SL, Richman DP, O'Connor KC, Herzberg U, Binder GK, Milone MC, Basu S, Payne AS. Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells. , Nat Biotechnol. : 2023

Christoph T. Ellebrecht, Aimee S. Payne Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment , Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment, 1st Edition, McGraw Hill: 2023

Wat M, Mollanazar NK, Ellebrecht CT, Forrestel A, Elenitsas R, Chu EY. Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade. , J Cutan Pathol. : 2022

Christoph T Ellebrecht, Casey Lee, Roderick O'Connor, Aimee S. Payne Asymmetric cell division for fate induction of chimeric antigen receptor (CAR) T cells , Annual Conference of the American Society for Gene and Cell Therapy: 2022

Ellebrecht CT, Maseda D, Payne AS. Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways. , J Invest Dermatol. : 2022

View all publications